|
| ID |
DDInter1771 |
| Drug Type |
small molecule |
| Molecular Formula |
C12H9F3N2O2 |
| Molecular Weight |
270.210
|
| Description |
Teriflunomide is a pyrimidine synthesis inhibitor with anti-inflammatory and immunomodulatory properties used to treat patients with the relapsing-remitting form of multiple sclerosis.
|
| ATC Classification |
L04AA31
|
| IUPAC Name |
(2Z)-2-Cyano-3-Hydroxy-N-[4-(Trifluoromethyl)Phenyl]But-2-Enamide |
| InChI |
Inchi=1S/C12H9F3N2O2/C1-7(18)10(6-16)11(19)17-9-4-2-8(3-5-9)12(13,14)15/H2-5,18H,1H3,(H,17,19)/B10-7- |
| InChI Key |
UTNUDOFZCWSZMS-YFHOEESVSA-N |
| Canonical SMILES |
C\C(O)=C(/C#N)C(=O)NC1=CC=C(C=C1)C(F)(F)F |
| Useful Links |
DrugBank
ChEMBL
PubChem
|